Literature DB >> 1572447

Chronic thromboembolic pulmonary hypertension: clinical picture and surgical treatment.

K M Moser1, W R Auger, P F Fedullo, S W Jamieson.   

Abstract

Chronic, major vessel thromboembolic pulmonary hypertension (CTEPH), is an uncommon condition which, in the past, was an autopsy curiosity. Advances in diagnostic approaches, surgical techniques and postoperative management have transformed this disorder into a potentially curable form of pulmonary hypertension. The predominant symptom is unexplained dyspnoea on exertion. In patients with this complaint, CTEPH should be considered. Numerous pitfalls exist along the diagnostic path. Perfusion lung scans point toward the diagnosis, but often underestimate the extent of central arterial obstruction. Pulmonary angiography is the key diagnostic procedure, but the many patterns of thrombus organization-recanalization require a base of experience for proper interpretation. Criteria for selection of patients for surgery are evolving, but assurance of thrombus accessibility to surgery is critical. Surgical thromboendarterectomy bears no resemblance to acute pulmonary embolectomy. Recognition of thrombus (versus normal intima), meticulous dissection and a bloodless surgical field are essential for adequate restoration of pulmonary vascular patency. Multiple complications may arise postoperatively, and detailed attention to these is required for patient survival. With a co-ordinated, multi-specialty team effort, however, haemodynamic and clinical outcomes have been rewarding and persist long-term. Surgical mortality should steadily decline with such a co-ordinated effort, as well as earlier diagnosis and advances in surgical and postoperative management techniques.

Entities:  

Mesh:

Year:  1992        PMID: 1572447

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  21 in total

1.  Recommendations on the management of pulmonary hypertension in clinical practice.

Authors: 
Journal:  Heart       Date:  2001-09       Impact factor: 5.994

2.  Diagnostic value of transoesophageal echocardiography in suspected haemodynamically significant pulmonary embolism.

Authors:  P Pruszczyk; A Torbicki; A Kuch-Wocial; M Szulc; R Pacho
Journal:  Heart       Date:  2001-06       Impact factor: 5.994

3.  Comparison of bronchopulmonary collaterals and collateral blood flow in patients with chronic thromboembolic and primary pulmonary hypertension.

Authors:  J Endrys; N Hayat; G Cherian
Journal:  Heart       Date:  1997-08       Impact factor: 5.994

4.  Brain abscess as a complication of chronic thromboembolic pulmonary hypertension - a rare case report.

Authors:  Lakshmi K; Santhanam R; Chitralekha S
Journal:  J Clin Diagn Res       Date:  2013-09-10

Review 5.  Pulmonary embolism in parenteral nutrition.

Authors:  C M Dollery
Journal:  Arch Dis Child       Date:  1996-02       Impact factor: 3.791

6.  Vascular stiffening in pulmonary hypertension: cause or consequence? (2013 Grover Conference series).

Authors:  Wei Tan; Krishna Madhavan; Kendall S Hunter; Daewon Park; Kurt R Stenmark
Journal:  Pulm Circ       Date:  2014-12       Impact factor: 3.017

7.  Long term treatment of pulmonary arterial hypertension with beraprost, an oral prostacyclin analogue.

Authors:  C D Vizza; S Sciomer; S Morelli; C Lavalle; P Di Marzio; D Padovani; R Badagliacca; A R Vestri; R Naeije; F Fedele
Journal:  Heart       Date:  2001-12       Impact factor: 5.994

Review 8.  Chronic pulmonary embolism: diagnosis.

Authors:  Katia Hidemi Nishiyama; Sachin S Saboo; Yuki Tanabe; Dany Jasinowodolinski; Michael J Landay; Fernando Uliana Kay
Journal:  Cardiovasc Diagn Ther       Date:  2018-06

Review 9.  The role of computed tomography in the diagnosis of acute and chronic pulmonary embolism.

Authors:  Halil Doğan; Albert de Roos; Jacob Geleijins; Menno V Huisman; Lucia J M Kroft
Journal:  Diagn Interv Radiol       Date:  2015 Jul-Aug       Impact factor: 2.630

10.  Long-term efficacy of bosentan in inoperable chronic thromboembolic pulmonary hypertension.

Authors:  M C Post; H W M Plokker; J C Kelder; R J Snijder
Journal:  Neth Heart J       Date:  2009-09       Impact factor: 2.380

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.